GB2456237B8 - Stable adenosine receptor mutants - Google Patents
Stable adenosine receptor mutantsInfo
- Publication number
- GB2456237B8 GB2456237B8 GB0901111A GB0901111A GB2456237B8 GB 2456237 B8 GB2456237 B8 GB 2456237B8 GB 0901111 A GB0901111 A GB 0901111A GB 0901111 A GB0901111 A GB 0901111A GB 2456237 B8 GB2456237 B8 GB 2456237B8
- Authority
- GB
- United Kingdom
- Prior art keywords
- gpcr
- ligand
- mutants
- binding
- adenosine receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000009346 Adenosine receptors Human genes 0.000 title abstract 2
- 108050000203 Adenosine receptors Proteins 0.000 title abstract 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 8
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 8
- 239000003446 ligand Substances 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 102000017922 Neurotensin receptor Human genes 0.000 abstract 1
- 108060003370 Neurotensin receptor Proteins 0.000 abstract 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 abstract 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0901111A GB2456237B8 (en) | 2007-03-22 | 2008-03-20 | Stable adenosine receptor mutants |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0705450A GB0705450D0 (en) | 2007-03-22 | 2007-03-22 | Mutant proteins and method for selecting them |
GB0724052A GB0724052D0 (en) | 2007-12-08 | 2007-12-08 | Mutant proteins and methods for selecting them |
GB0805267A GB2447786C (en) | 2007-03-22 | 2008-03-20 | Mutant G-protein coupled receptor proteins and methods for selecting them |
GB0901111A GB2456237B8 (en) | 2007-03-22 | 2008-03-20 | Stable adenosine receptor mutants |
Publications (4)
Publication Number | Publication Date |
---|---|
GB0901111D0 GB0901111D0 (en) | 2009-03-11 |
GB2456237A GB2456237A (en) | 2009-07-15 |
GB2456237B GB2456237B (en) | 2009-10-28 |
GB2456237B8 true GB2456237B8 (en) | 2009-12-09 |
Family
ID=39386585
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0805267A Active GB2447786C (en) | 2007-03-22 | 2008-03-20 | Mutant G-protein coupled receptor proteins and methods for selecting them |
GB0901111A Active GB2456237B8 (en) | 2007-03-22 | 2008-03-20 | Stable adenosine receptor mutants |
GB0901110A Active GB2456236B8 (en) | 2007-03-22 | 2008-03-20 | Stable muscarinic receptor mutants |
GB0901095A Active GB2456235B8 (en) | 2007-03-22 | 2008-03-20 | Stable beta-adrenergic receptor mutants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0805267A Active GB2447786C (en) | 2007-03-22 | 2008-03-20 | Mutant G-protein coupled receptor proteins and methods for selecting them |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0901110A Active GB2456236B8 (en) | 2007-03-22 | 2008-03-20 | Stable muscarinic receptor mutants |
GB0901095A Active GB2456235B8 (en) | 2007-03-22 | 2008-03-20 | Stable beta-adrenergic receptor mutants |
Country Status (14)
Country | Link |
---|---|
US (7) | US8785135B2 (pl) |
EP (4) | EP3926045A1 (pl) |
JP (6) | JP4842400B2 (pl) |
CN (2) | CN103641908A (pl) |
AT (1) | ATE544854T1 (pl) |
AU (1) | AU2008228085B2 (pl) |
CA (1) | CA2681415C (pl) |
DK (1) | DK2121919T3 (pl) |
ES (1) | ES2381780T3 (pl) |
GB (4) | GB2447786C (pl) |
HR (1) | HRP20120336T1 (pl) |
PL (1) | PL2121919T3 (pl) |
PT (1) | PT2121919E (pl) |
WO (1) | WO2008114020A2 (pl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3926045A1 (en) | 2007-03-22 | 2021-12-22 | Heptares Therapeutics Limited | Mutant proteins and methods for selecting them |
GB0724051D0 (en) * | 2007-12-08 | 2008-01-16 | Medical Res Council | Mutant proteins and methods for producing them |
GB0724860D0 (en) | 2007-12-20 | 2008-01-30 | Heptares Therapeutics Ltd | Screening |
GB0802474D0 (en) * | 2008-02-11 | 2008-03-19 | Heptares Therapeutics Ltd | Mutant proteins and methods for selecting them |
DE08718604T1 (de) * | 2008-03-05 | 2009-12-24 | Medical Research Council | Kristallstruktur |
GB0910725D0 (en) | 2009-06-22 | 2009-08-05 | Heptares Therapeutics Ltd | Mutant proteins and methods for producing them |
GB201014715D0 (en) | 2010-09-06 | 2010-10-20 | Vib Vzw | Nanobodies stabilizing functional conformational states of GPCRS |
US8900591B2 (en) | 2010-08-20 | 2014-12-02 | Heptares Therapeutics Limited | Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors |
US20140031525A1 (en) * | 2011-01-21 | 2014-01-30 | Heptares Therapeutics Limited | Mutant g-protein coupled receptor proteins and methods for producing them |
WO2012116203A1 (en) | 2011-02-23 | 2012-08-30 | Massachusetts Institute Of Technology | Water soluble membrane proteins and methods for the preparation and use thereof |
WO2012120315A2 (en) | 2011-03-10 | 2012-09-13 | Heptares Therapeutics Limited | Mutant proteins and methods for producing them |
WO2013021206A2 (en) | 2011-08-10 | 2013-02-14 | Heptares Therapeutics Limited | Stable proteins |
JP6251252B2 (ja) * | 2012-06-01 | 2017-12-20 | ヘプタレス セラピューティックス リミテッド | アッセイ |
JP6443344B2 (ja) | 2013-01-30 | 2018-12-26 | フエー・イー・ベー・フエー・ゼツト・ウエー | スクリーニングおよび薬物開発のための新規キメラポリペプチド |
EP2970425B1 (en) | 2013-03-15 | 2019-10-30 | United Kingdom Research and Innovation | Mutant membrane proteins and methods for their production |
WO2014176524A2 (en) | 2013-04-25 | 2014-10-30 | The Trustees Of The University Of Pennsylvania | Opioid detection based on high quality graphene transistor arrays and a synthetic mu receptor |
WO2014176544A1 (en) * | 2013-04-25 | 2014-10-30 | The Trustees Of The University Of Pennsylvania | Water soluble g-protein coupled receptor |
CA2914831C (en) | 2013-06-11 | 2022-10-11 | Paul Scherrer Institut | Method for determining mutateable ligand-gpcr binding at single amino acid resolution and pairs of mutated ligand and gpcr |
US10373702B2 (en) | 2014-03-27 | 2019-08-06 | Massachusetts Institute Of Technology | Water-soluble trans-membrane proteins and methods for the preparation and use thereof |
CN104151401A (zh) * | 2014-06-05 | 2014-11-19 | 维亚生物科技(上海)有限公司 | 融合表达离子通道蛋白及运输蛋白的方法及其使用的蛋白片断 |
GB2527286A (en) | 2014-06-11 | 2015-12-23 | Rsr Ltd | Glycoprotein hormone receptor mutations |
US10287349B2 (en) | 2014-10-31 | 2019-05-14 | Abilita Bio, Inc. | Modified membrane spanning proteins and methods for the preparation and use thereof |
JP6722951B2 (ja) | 2015-07-31 | 2020-07-15 | 国立研究開発法人理化学研究所 | 膜タンパク質の製造方法およびその利用 |
GB201601690D0 (en) | 2016-01-29 | 2016-03-16 | Heptares Therapeutics Ltd | G proteins |
EP3205450A1 (de) * | 2016-02-09 | 2017-08-16 | Hermes Schleifkörper GmbH | Verfahren zur herstellung eines keramischen formkörpers |
CN109415445A (zh) | 2016-05-04 | 2019-03-01 | 阿比利塔生物公司 | 用于制备多跨膜蛋白的方法和平台 |
CN109553687B (zh) * | 2017-09-27 | 2021-07-06 | 北京大学 | 基于g蛋白偶联受体构建的荧光探针 |
CN114038498B (zh) * | 2022-01-06 | 2022-03-18 | 北京晶泰科技有限公司 | Gpcr的热稳定性突变预测方法、结构筛选方法及其装置 |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US6780613B1 (en) | 1988-10-28 | 2004-08-24 | Genentech, Inc. | Growth hormone variants |
CA2345497A1 (en) | 1988-10-28 | 1990-04-28 | Genentech, Inc. | Growth hormone variants and method for forming growth hormone variants |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
JPH06508511A (ja) | 1990-07-10 | 1994-09-29 | ケンブリッジ アンティボディー テクノロジー リミティド | 特異的な結合ペアーの構成員の製造方法 |
DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
EP0575485A1 (en) | 1991-03-01 | 1993-12-29 | Dyax Corp. | Process for the development of binding mini-proteins |
JP3147916B2 (ja) | 1991-03-08 | 2001-03-19 | 森永製菓株式会社 | 体外免疫方法 |
JP3672306B2 (ja) | 1991-04-10 | 2005-07-20 | ザ スクリップス リサーチ インスティテュート | ファージミドを使用するヘテロ二量体受容体ライブラリー |
DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
US20030036092A1 (en) | 1991-11-15 | 2003-02-20 | Board Of Regents, The University Of Texas System | Directed evolution of enzymes and antibodies |
EP0644935A1 (en) * | 1992-06-12 | 1995-03-29 | Garvan Institute Of Medical Research | DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS |
US5585277A (en) | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
EP0763202A4 (en) | 1994-05-23 | 1998-12-09 | Smithkline Beecham Corp | ENCODED COMBINATORIAL LIBRARIES |
US20020028443A1 (en) | 1999-09-27 | 2002-03-07 | Jay M. Short | Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
WO1997035881A2 (en) | 1996-03-27 | 1997-10-02 | Ng Gordon Y K | Receptor and transporter antagonists |
CA2250975A1 (en) | 1996-04-15 | 1997-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
US6153410A (en) | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
JP2002510505A (ja) | 1998-04-03 | 2002-04-09 | フィロス インク. | 位置特定可能な蛋白質アレイ |
EP1070257A2 (en) | 1998-04-06 | 2001-01-24 | Lerner Pharmaceuticals, Inc. | Directed evolution biosensors |
US6692696B1 (en) | 1998-06-18 | 2004-02-17 | ARETé ASSOCIATES | Biosensor |
WO2000012705A2 (en) * | 1998-09-01 | 2000-03-09 | Basf Aktiengesellschaft | Methods for improving the function of heterologous g protein-coupled receptors |
US7094593B1 (en) | 1998-09-01 | 2006-08-22 | Basf Aktiengesellschaft | Method for improving the function of heterologous G protein-coupled receptors |
WO2000070343A2 (en) | 1999-05-14 | 2000-11-23 | Repliscent, Inc. | G-protein coupled receptor based biosensors and sense replication systems |
EP1242448A2 (en) * | 1999-11-17 | 2002-09-25 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human g protein-coupled receptors |
AU2001243145A1 (en) | 2000-02-09 | 2001-08-20 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor (ccr5) hdgnr10 |
US7678539B2 (en) | 2000-08-10 | 2010-03-16 | Corning Incorporated | Arrays of biological membranes and methods and use thereof |
WO2002018590A2 (en) | 2000-08-30 | 2002-03-07 | John Hopkins University School Of Medicine | Identification of activated receptors and ion channels |
US6448377B1 (en) | 2000-09-27 | 2002-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Modified G protein sunbunits |
CA2425149A1 (en) | 2000-10-26 | 2002-08-01 | New England Medical Center Hospitals, Inc. | Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents |
US20030232331A1 (en) | 2000-12-05 | 2003-12-18 | Casman Stacie J. | Novel proteins and nucleic acids encoding same |
JP2005503124A (ja) * | 2001-02-14 | 2005-02-03 | アムジェン インコーポレイテッド | Gタンパク質共役受容体分子及びその使用 |
CA2439383A1 (en) * | 2001-02-26 | 2002-09-06 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human g protein-coupled receptors |
US7294472B2 (en) | 2001-03-14 | 2007-11-13 | Caden Biosciences | Method for identifying modulators of G protein coupled receptor signaling |
US7208279B2 (en) | 2001-03-14 | 2007-04-24 | Caden Biosciences, Inc. | Method for identifying inhibitors of G protein coupled receptor signaling |
US20070010948A1 (en) | 2001-03-30 | 2007-01-11 | Masaji Ishiguro | G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model |
US20030129649A1 (en) | 2001-04-24 | 2003-07-10 | Kobilka Brian K. | Conformational assays to detect binding to G protein-coupled receptors |
US20050009204A1 (en) | 2003-07-11 | 2005-01-13 | Ye Fang | Multiplexed binding assays for receptor arrays |
ATE340190T1 (de) | 2001-10-25 | 2006-10-15 | Astex Therapeutics Ltd | Cytochrome p450 2c9 kristalle, strukturen und dessen verwendung |
US7115377B2 (en) | 2001-10-26 | 2006-10-03 | Atto Bioscience, Inc. | Cell-based assays for G-protein-coupled receptor-mediated activities |
AU2003227268A1 (en) | 2002-03-28 | 2003-10-13 | Takeda Chemical Industries, Ltd. | Novel screening method |
JP2004238384A (ja) * | 2002-03-28 | 2004-08-26 | Takeda Chem Ind Ltd | 新規スクリーニング方法 |
CA2483701A1 (en) * | 2002-04-24 | 2003-11-06 | Banyu Pharmaceutical Co., Ltd. | Constitutively active histamine h3 receptor mutants and uses thereof |
ES2340475T3 (es) | 2002-05-01 | 2010-06-04 | Vertex Pharmaceuticals Incorporated | Estructura cristalizada de proteina aurora-2 y sus bolsillos de union. |
AU2002951995A0 (en) * | 2002-10-11 | 2002-10-31 | Alchemia Limited | Classes of compounds that interact with gpcrs |
US20040096914A1 (en) | 2002-11-20 | 2004-05-20 | Ye Fang | Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof |
AU2004241193B2 (en) * | 2003-05-20 | 2011-03-10 | The University Court Of The University Of Glasgow | Materials and methods relating to G-protein coupled receptor oligomers |
US7745161B2 (en) | 2003-12-19 | 2010-06-29 | Palo Alto Research Center Incorporated | Amplification of enzymatic reactions for use with an enthalpy array |
US20060281699A1 (en) | 2004-05-12 | 2006-12-14 | Merchiers Pascal G | Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
WO2005121755A1 (en) | 2004-06-14 | 2005-12-22 | Commonwealth Scientific And Industrial Research Organisation | Cell free g-protein coupled receptor and ligand assay |
US20060188964A1 (en) | 2004-07-28 | 2006-08-24 | Filippo Mancia | Processing for producing and crystallizing G-protein coupled receptors |
JP2006340717A (ja) * | 2005-05-11 | 2006-12-21 | Sekisui Chem Co Ltd | Gタンパク質共役型受容体に対する結合性評価方法及び評価用組成物、融合タンパク質、並びに、遺伝子 |
FR2890174B1 (fr) | 2005-08-30 | 2009-04-24 | Cis Bio Internat Sa | Procede pour la mise en evidence d'un processus biologique par mesure d'un fret |
US20070154947A1 (en) | 2005-08-31 | 2007-07-05 | The Trustees Of Princeton University | Chemical biodiscriminator |
EP1948232A4 (en) | 2005-11-18 | 2010-09-22 | Univ Ohio State Res Found | VIRAL GENE PRODUCTS AND VACCINATION METHODS FOR PREVENTING ASSOCIATED VIRAL DISEASES |
US7495024B2 (en) * | 2006-08-07 | 2009-02-24 | Via Pharmaceuticals, Inc. | Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque |
EP3926045A1 (en) * | 2007-03-22 | 2021-12-22 | Heptares Therapeutics Limited | Mutant proteins and methods for selecting them |
WO2009051769A1 (en) | 2007-10-17 | 2009-04-23 | The Board Of Trustees Of The Leland Stanford Junior University | Method and composition for crystallizing g protein-coupled receptors |
JP5560448B2 (ja) | 2007-10-22 | 2014-07-30 | ザ スクリプス リサーチ インスティテュート | 膜タンパク質の高分解能結晶を得るための方法および組成物 |
GB0724051D0 (en) | 2007-12-08 | 2008-01-16 | Medical Res Council | Mutant proteins and methods for producing them |
GB0724860D0 (en) | 2007-12-20 | 2008-01-30 | Heptares Therapeutics Ltd | Screening |
GB0802474D0 (en) | 2008-02-11 | 2008-03-19 | Heptares Therapeutics Ltd | Mutant proteins and methods for selecting them |
DE08718604T1 (de) | 2008-03-05 | 2009-12-24 | Medical Research Council | Kristallstruktur |
GB0910725D0 (en) | 2009-06-22 | 2009-08-05 | Heptares Therapeutics Ltd | Mutant proteins and methods for producing them |
US8900591B2 (en) | 2010-08-20 | 2014-12-02 | Heptares Therapeutics Limited | Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors |
WO2012030735A1 (en) | 2010-08-30 | 2012-03-08 | Confometrx, Inc. | Method and composition for crystallizing a family c gpcr |
US20140031525A1 (en) | 2011-01-21 | 2014-01-30 | Heptares Therapeutics Limited | Mutant g-protein coupled receptor proteins and methods for producing them |
US20120288913A1 (en) | 2011-05-13 | 2012-11-15 | The Scripps Research Institute | Novel fusion partners for the purpose of crystallizing g-protein coupled receptors |
WO2013021206A2 (en) | 2011-08-10 | 2013-02-14 | Heptares Therapeutics Limited | Stable proteins |
EP2617732A1 (en) | 2012-01-19 | 2013-07-24 | Vib Vzw | Tools and methods for expression of membrane proteins |
WO2013142278A1 (en) | 2012-03-22 | 2013-09-26 | New York University | Plasmodium vivax vaccine compositions |
JP6251252B2 (ja) | 2012-06-01 | 2017-12-20 | ヘプタレス セラピューティックス リミテッド | アッセイ |
WO2014028644A1 (en) | 2012-08-15 | 2014-02-20 | Cyvax, Inc. | Methods and compositions for preventing a condition |
US20150261911A1 (en) | 2014-03-13 | 2015-09-17 | Heptares Therapeutics Limited | Crystal structure |
-
2008
- 2008-03-20 EP EP21171713.7A patent/EP3926045A1/en active Pending
- 2008-03-20 EP EP08718823A patent/EP2121919B1/en active Active
- 2008-03-20 AT AT08718823T patent/ATE544854T1/de active
- 2008-03-20 CN CN201310556727.3A patent/CN103641908A/zh active Pending
- 2008-03-20 EP EP12153522A patent/EP2450445A1/en not_active Ceased
- 2008-03-20 GB GB0805267A patent/GB2447786C/en active Active
- 2008-03-20 WO PCT/GB2008/000986 patent/WO2008114020A2/en active Application Filing
- 2008-03-20 AU AU2008228085A patent/AU2008228085B2/en active Active
- 2008-03-20 ES ES08718823T patent/ES2381780T3/es active Active
- 2008-03-20 CA CA2681415A patent/CA2681415C/en active Active
- 2008-03-20 GB GB0901111A patent/GB2456237B8/en active Active
- 2008-03-20 GB GB0901110A patent/GB2456236B8/en active Active
- 2008-03-20 CN CN2008800093780A patent/CN101688203B/zh active Active
- 2008-03-20 EP EP11075136A patent/EP2386635A3/en not_active Ceased
- 2008-03-20 PT PT08718823T patent/PT2121919E/pt unknown
- 2008-03-20 DK DK08718823.1T patent/DK2121919T3/da active
- 2008-03-20 JP JP2010500347A patent/JP4842400B2/ja active Active
- 2008-03-20 GB GB0901095A patent/GB2456235B8/en active Active
- 2008-03-20 US US12/450,358 patent/US8785135B2/en active Active
- 2008-03-20 PL PL08718823T patent/PL2121919T3/pl unknown
-
2011
- 2011-08-05 JP JP2011171887A patent/JP2011224018A/ja active Pending
-
2012
- 2012-04-16 HR HRP20120336AT patent/HRP20120336T1/hr unknown
- 2012-06-11 US US13/493,898 patent/US20120270230A1/en not_active Abandoned
-
2014
- 2014-05-14 JP JP2014100213A patent/JP2014155502A/ja active Pending
-
2015
- 2015-08-26 US US14/836,820 patent/US20160052991A1/en not_active Abandoned
-
2016
- 2016-06-30 JP JP2016129938A patent/JP6426661B2/ja active Active
-
2017
- 2017-09-26 US US15/716,302 patent/US20180086814A1/en not_active Abandoned
-
2018
- 2018-07-19 JP JP2018135756A patent/JP2018164456A/ja active Pending
- 2018-12-10 US US16/215,533 patent/US20190241644A1/en not_active Abandoned
-
2020
- 2020-05-11 US US16/871,254 patent/US11673938B2/en active Active
- 2020-11-20 JP JP2020193343A patent/JP7419217B2/ja active Active
-
2023
- 2023-04-21 US US18/304,801 patent/US20240052017A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2456237B8 (en) | Stable adenosine receptor mutants | |
WO2009081136A3 (en) | Screening | |
WO2009071914A3 (en) | Mutant proteins and methods for producing them | |
WO2007082144A3 (en) | B7-h1 and survivin in cancer | |
WO2009073664A3 (en) | Rating raters | |
WO2008109878A3 (en) | Testing device | |
SG144146A1 (en) | Adenosine receptor agonists | |
EP2068544A4 (en) | VOICE MIXING METHOD, MULTIPOINT CONFERENCE SERVER USING THE METHOD AND PROGRAM | |
WO2010075084A3 (en) | User interface tools | |
WO2009026189A3 (en) | Methods and apparatus for providing location data with variable validity and quality | |
EP2310844A4 (en) | Systems and methods for determining geologic properties using acoustic analysis | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
ATE544870T1 (de) | Profilierung einer rezeptorfamilie | |
TW200634624A (en) | System, apparatus and method of selecting graphical component types at runtime | |
WO2009018359A3 (en) | Selecting and applying a communication version | |
WO2006015084A3 (en) | Compositions, kits and assays containing reagents directed to cortactin and an arg/abl protein kinase | |
WO2011092504A3 (en) | Biomarkers for schizophrenia | |
WO2010040003A3 (en) | Human a2a adenosine receptor crystals and uses thereof | |
WO2007132359A3 (en) | Composition containing lactobacillus sp. and a cannabinoid receptor and/or a opioid receptor agonist | |
WO2007047686A3 (en) | Brochure creation internet system | |
WO2007101116A3 (en) | Glur2 receptor modulators | |
WO2006104761A3 (en) | Unique sequence hybridization probes (usp) | |
TW200700727A (en) | Screen | |
O'Dale | BUILDING PRIVATE AND PUBLIC SECTOR SUPPORT FOR SPACE RESOURCE USE | |
Ghic | USING DIFFERENT ELECTRE METHODS IN MULTICRITERIAL DECISIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20090924 AND 20090930 |